ArticleBMC bioinformatics2026
A multi-tissue mendelian randomization method based on eQTL data for mapping tissue-specific disease genes.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tissue-specific gene expression is critical in complex disease etiology, but traditional transcriptome-wide Mendelian Randomization (TWMR) often overlooks tissue heterogeneity and is constrained by limited valid instrumental variables (IVs) per tissue. We propose Multi-Tissue TWMR (MT-TWMR), which selects cis-eQTLs with consistent effects across tissues as IVs and estimates tissue-specific causal effects via a penalized regression model combining L1 regularization for sparsity with a weighted tissue-difference penalty based on tissue similarity to enable cross-tissue information sharing. Simulations under varying IV numbers, pleiotropy levels, and tissue counts showed MT-TWMR consistently achieved higher power, lower root mean square error, and better type I error control than existing univariate and multivariable MR methods, particularly when IVs were scarce. Applied to major depressive disorder and primary hypertension, MT-TWMR identified 28 and 57 causal genes respectively, with enriched signals in biologically relevant tissues and strong colocalization and pathway evidence. MT-TWMR offers an effective and interpretable framework for integrating multi-tissue eQTL data to construct tissue-specific disease gene maps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.